首页> 美国卫生研究院文献>BMC Pediatrics >A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol

【2h】

A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol

机译：基于IDRF的手术决策和逐步加强治疗对中度危险神经母细胞瘤患者的II期JN-I-10疗效研究：研究方案

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Study flow chart of JN-I-10

机译：JN-I-10的研究流程图

著录项

期刊名称 BMC Pediatrics
作者
Tomoko Iehara; Akihiro Yoneda; Atsushi Kikuta; Toshihiro Muraji; Kazuaki Tokiwa; Hideto Takahashi; Satoshi Teramukai; Tetsuya Takimoto; Shigeki Yagyu; Hajime Hosoi; Tatsuro Tajiri; the Japan Children’s Cancer Group Neuroblastoma Committee;
展开▼
作者单位

展开▼
年(卷),期 2020(20),-1
年度 2020
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类儿科学;
关键词
Neuroblastoma; Intermediate risk; IDRF;

机译：神经母细胞瘤;中度风险;IDRF;

相似文献

外文文献
中文文献
专利

1. A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol [J] . Tomoko Iehara, Akihiro Yoneda, Atsushi Kikuta, BMC Pediatrics . 2020,第1期

机译：IDRF基于IDRF的外科手术决策的II期JN-I-10疗效研究和中间风险神经母细胞瘤患者的逐步治疗强化：研究方案
2. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol [J] . Alice Boilève, Aline Maillard, Mathilde Wagner, BMC Cancer . 2020,第1期

机译：肝动脉输液化疗的治疗肝脏肝脏输液化疗患者肝脏直肠转移患者仍然不可切除，后系统诱导化疗后仍然不可切除 - 一种随机期II研究 - 苏丹UCGI 30 / PRODIGE 53（NCT03164655） - 研究方案 - 研究方案
3. Phase II Randomised Controlled Trial of a patient decision-aid website to improve treatment decision-making for young adults with bipolar II disorder: A feasibility study protocol [J] . Alana Fisher, Louise Sharpe, Daniel Costa, Contemporary Clinical Trials Communications . 2018,第3期

机译：患者决策援助网站的II期随机对照试验，以改善患有双相II型情感障碍的年轻成年人的治疗决策：一项可行性研究方案
4. Efficacy Analysis of Preservative-Free Tafluprost and Timolol in Open-Angle Glaucoma and OHT Patients in a Phase-III Study [C] . GrundenJ., Lupinacci R. International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：在第三阶段研究中，在开放角度荧光眼和OHT患者中无防腐型TaFluprost和蒂莫尔的疗效分析
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. A Phase II Multi-Center Non-Randomized Parallel Group Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol [O] . Eun Kyung Lee, You Jin Lee, Young Joo Park, 2020

机译：II期多中心非随机性平行组非劣液性研究以比较NO放射性碘残余烧蚀与低对乳头状甲状腺癌中风险的残留烧蚀处理的疗效：Morethyroid试验方案
7. A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol [O] . Tomoko Iehara, Akihiro Yoneda, Atsushi Kikuta, 2020

机译：IDRF基于IDRF的外科手术决策的II期JN-I-10疗效研究和中间风险神经母细胞瘤患者的逐步治疗强化：研究方案

A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol

摘要

著录项

相似文献

相关主题

期刊订阅